|
| |
| | | 69956 | | 07.10.2025 | | Gebro Pharma AG | | | | | | | 06.10.2030 | | | | | | 01.07.10. | | | | 01.07.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Dalingo 82.5 mg | Retardtabletten | Delayed release tablets (Pregabalin 82.5 mg) | N03AX16 | CI | | 02 | Dalingo 165 mg | Retardtabletten | Delayed release tablets (Pregabalin 165 mg) | N03AX16 | CI | | 03 | Dalingo 330 mg | Retardtabletten | Delayed release tablets (Pregabalin 330 mg) | N03AX16 | CI |
|
|
|
